武汉云克隆科技股份有限公司

血管内皮生长因子受体1(VEGFR1)重组蛋白

Recombinant Vascular Endothelial Growth Factor Receptor 1 (VEGFR1)

Flt1; Fms-Related Tyrosine Kinase 1; Vascular Permeability Factor Receptor; Fms-like tyrosine kinase 1; Tyrosine-protein kinase receptor FLT

  • 血管内皮生长因子受体1(VEGFR1)重组蛋白产品包装(模拟)
  • 血管内皮生长因子受体1(VEGFR1)重组蛋白产品包装(模拟)
  • RPB818Po01.jpgFigure. SDS-PAGE
  • Certificate通过ISO 9001、ISO 13485质量体系认证

序列

用法

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

储存

避免反复冻融。2-8°C不超过一个月，-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。

相关产品

编号适用物种：Sus scrofa; Porcine (Pig，猪)应用(仅供研究使用，不用于临床诊断！)
RPB818Po01血管内皮生长因子受体1(VEGFR1)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPB818Po02血管内皮生长因子受体1(VEGFR1)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAB818Po02血管内皮生长因子受体1(VEGFR1)多克隆抗体WB; IHC; ICC; IP.
PAB818Po01血管内皮生长因子受体1(VEGFR1)多克隆抗体WB; IHC; ICC; IP.
LAB818Po81血管内皮生长因子受体1(VEGFR1)多克隆抗体(异硫氰酸荧光素标记)WB; IHC; ICC; IF.
LAB818Po71血管内皮生长因子受体1(VEGFR1)多克隆抗体(生物素标记)WB; IHC; ICC.
LAB818Po73血管内皮生长因子受体1(VEGFR1)多克隆抗体(生物素标记)WB; IHC; ICC.
LAB818Po72血管内皮生长因子受体1(VEGFR1)单克隆抗体(生物素标记)WB; IHC; ICC.
SEB818Po血管内皮生长因子受体1(VEGFR1)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMB818Po血管内皮生长因子受体1(VEGFR1)等多因子检测试剂盒(流式荧光发光法)FLIA Kit for Antigen Detection.

参考文献

杂志参考文献
Clinical cardiologyGrowth Differentiation Factor 15 and Coronary Collateral Formation[PubMed: 20014173]
Microvascular ResearchMutant hypoxia inducible factor-1α improves angiogenesis and tissue perfusion in ischemic rabbit skeletal muscle [PubMed: 20937289]
Science AlertAntiangiogenic Activities of Cinnamon, Black and Green Tea Extracts on Experimentally Induced Breast Cancer in Rats[Scialert: Source]
Acta BiomaterAntioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: an in vitro osteoblast-osteoclast-endothelial cell co-culture study[PubMed: 26689470]
Naunyn Schmiedebergs Arch PharmacolThe multi-kinase inhibitor pazopanib targets hepatic stellate cell activation and apoptosis alleviating progression of liver fibrosis[PubMed: 26269412]
Acta BiomaterialiaAntioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: An in vitro osteoblast–osteoclast–endothelial cell co-culture study[Pubmed:26689470]
Journal of Cellular PhysiologyA Human 3D In Vitro Model to Assess the Relationship Between Osteoporosis and Disseminationto Bone of Breast Cancer Tumor Cells.[pubmed:27925188]
OncotargetFasudil attenuates soluble fms-like tyrosine kinase-1 (sFlt-1)-induced hypertension in pregnant mice through RhoA/ROCK pathway.[pubmed:29262624]
PlacentaModulating circulating sFlt1 in an animal model of preeclampsia using PAMAM nanoparticles for siRNA delivery.[pubmed:28962687]
Acta BiomaterialiaSynergistic effect of Si-hydroxyapatite coating and VEGF adsorption on Ti6Al4V-ELI scaffolds for bone regeneration in an osteoporotic bone environment[Pubmed: 30445158]
Scientific ReportsAssociation between Upper-airway Surgery and Ameliorative Risk Markers of endothelial function in obstructive Sleep Apnea[Pubmed: 31882827]
JOURNAL OF DERMATOLOGICAL TREATMENTEffect of isotretinoin (13-cis-retinoic acid) on levels of soluble VEGF receptors (sVEGFR1, sVEGFR2, sVEGFR3) in patients with acne vulgaris[Pubmed: 32043381]
FASEB JOURNALCyclin G2 upregulation impairs migration, invasion, and network formation through RNF123/Dvl2/JNK signaling in the trophoblast cell line HTR8/SVneo, a possible …[Pubmed: 33205477]
Children (Basel)sFlt-1/PlGF Ratio in Prediction of Short-Term Neonatal Outcome of Small for Gestational Age Neonates[34438609]
Oxid Med Cell LongevReactive Oxygen Species are Essential for Placental Angiogenesis During Early Gestation[Pubmed:35693704]